| mRNA |
Erlotinib |
CTRPv2 |
pan-cancer |
AAC |
0.21 |
8e-07 |
| mRNA |
Gefitinib |
GDSC1000 |
pan-cancer |
AAC |
0.19 |
2e-06 |
| mRNA |
TW 37 |
GDSC1000 |
pan-cancer |
AAC |
-0.19 |
3e-06 |
| mRNA |
Gefitinib |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
7e-06 |
| mRNA |
selumetinib:piperlongumine (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
2e-05 |
| mRNA |
GSK269962A |
GDSC1000 |
pan-cancer |
AAC |
-0.17 |
2e-05 |
| mRNA |
selumetinib:MK-2206 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
2e-05 |
| mRNA |
selumetinib:UNC0638 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
3e-05 |
| mRNA |
EKB-569 |
GDSC1000 |
pan-cancer |
AAC |
0.16 |
4e-05 |
| mRNA |
CP724714 |
GDSC1000 |
pan-cancer |
AAC |
0.17 |
7e-05 |